Huge Successful €103M IPO for the Next European Leader in Bioplastics
Avantium has gone public and raised €103M on Euronext Amsterdam and Euronext Bruxelles with Sofinnova…
Avantium has gone public and raised €103M on Euronext Amsterdam and Euronext Bruxelles with Sofinnova…
The Swedish company Oncopeptides raised €68M with its IPO on Nasdaq Stockholm, which will allow…
UPDATE (17/02/2017): Arix Bioscience announced that it has successfully raised £100M (€117) in an oversubscribed IPO on…
Inventiva has completed an IPO on Euronext Paris raising €48M that will support the advancement of its…
Lysogene has raised €22.6M from its IPO on Euronext Paris that will contribute to the completion…
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this…
Troubled waters in the CRISPR field: CRISPR Therapeutics' IPO hits an unexpectedly low price. It…
GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who…
It's not the $700M headlines imply, but AC Immune is winding up to make a…
The wait is over: CRISPR Therapeutics has turned up the heat on its rivals with…
We last wrote about GeNeuro in January, when they announced the launch of an IPO…